Acadian Asset Management
RNTX

Acadian Asset Management’s Rein Therapeutics RNTX Stock Holding History

Acadian Asset Management’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
17
– – ﹤0.01% 2303
2026
Q1 		$0 Hold
17
– – ﹤0.01% 2289
2025
Q4 		$0 Hold
17
– – ﹤0.01% 2156
2025
Q3 		$0 Hold
17
– – ﹤0.01% 2048
2025
Q2 		$0 Hold
17
– – ﹤0.01% 1875
2025
Q1 		$0 Hold
17
– – ﹤0.01% 1845
2024
Q4 		$0 Hold
17
– – ﹤0.01% 2249
2024
Q3 		$0 Hold
17
– – ﹤0.01% 2390
2024
Q2 		$0 Hold
17
– – ﹤0.01% 1924
2024
Q1 		$0 Hold
17
– – ﹤0.01% 1824
2023
Q4 		$0 Hold
17
– – ﹤0.01% 1852
2023
Q3 		$0 Hold
17
– – ﹤0.01% 1888
2023
Q2 		$0 Hold
17
– – ﹤0.01% 1943
2023
Q1 		$0 Hold
17
– – ﹤0.01% 2008
2022
Q4 		$0 Hold
17
– – ﹤0.01% 1939
2022
Q3 		$0 Hold
17
– – ﹤0.01% 1885
2022
Q2 		$0 Hold
17
– – ﹤0.01% 1894
2022
Q1 		$0 Sell
17
-4,247
-100% -$38.4K ﹤0.01% 1841
2021
Q4 		$47K Buy
+4,264
New +$65.9K ﹤0.01% 1500
2021
Q2 		– Sell
-6,721
Closed -$192K – 2251
2021
Q1 		$192K Buy
6,721
+1,582
+31% +$54.2K ﹤0.01% 1514
2020
Q4 		$107K Buy
5,139
+3,104
+153% +$77.6K ﹤0.01% 1725
2020
Q3 		$53K Buy
+2,035
New +$47.9K ﹤0.01% 1844
2020
Q2 		– Sell
-794
Closed -$5K – 2360
2020
Q1 		$5K Buy
+794
New +$9.56K ﹤0.01% 1740

Other funds holding RNTX

VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Acadian Asset Management's RNTX Position: Q2 2026 in Review

Acadian Asset Management held its Rein Therapeutics (RNTX) position steady in Q2 2026 at 17 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2303.

Acadian Asset Management first reported a position in RNTX in Q1 2020 and has held it in 23 quarters since. The position peaked at $192K in Q1 2021. 60 funds tracked by Wall St. Rank hold RNTX as of Q2 2026.

  • Acadian Asset Management held 17 shares of Rein Therapeutics worth $0 as of Q2 2026.
  • Acadian Asset Management left its Rein Therapeutics share count unchanged in Q2 2026.
  • Rein Therapeutics made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #2303 holding.
  • Acadian Asset Management first reported a position in Rein Therapeutics in Q1 2020 and has held it in 23 quarters since.
  • Acadian Asset Management's Rein Therapeutics position peaked at $192K in Q1 2021.
  • 60 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.